Effects of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Reverse Transcriptase Processing, Activity, and Drug Sensitivity

Antzeko izenburuak

• Constrained Evolution of Human Immunodeficiency Virus Type 1 Protease during Sequential Therapy with Two Distinct Protease Inhibitors
  nork: Dulioust, Anne, et al.
  Argitaratua: (1999)
• Quantification of the Effects on Viral DNA Synthesis of Reverse Transcriptase Mutations Conferring Human Immunodeficiency Virus Type 1 Resistance to Nucleoside Analogues
  nork: Bouchonnet, Francine, et al.
  Argitaratua: (2005)
• Role of Minority Populations of Human Immunodeficiency Virus Type 1 in the Evolution of Viral Resistance to Protease Inhibitors
  nork: Charpentier, Charlotte, et al.
  Argitaratua: (2004)
• Loss of Viral Fitness Associated with Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors In Vivo
  nork: Zennou, Véronique, et al.
  Argitaratua: (1998)
• Susceptibility of the Porcine Endogenous Retrovirus to Reverse Transcriptase and Protease Inhibitors
  nork: Qari, Shoukat H., et al.
  Argitaratua: (2001)